Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 9Carcinoma, Non-Small-Cell Lung 8Prostatic Neoplasms 6Glioblastoma 4Colorectal Neoplasms 4Breast Neoplasms 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Melanoma 2Lymphoma, Follicular 2Lymphoma 2Hodgkin Disease 2Ganglioneuroblastoma 2Clear-cell metastatic renal cell carcinoma 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Astrocytoma 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Sarcoma, Kaposi 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma 1Rectal Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

gadopiclenol 1gadobutrol 1fludarabine 1Magnetic Resonance Spectroscopy 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Meningeal Neoplasms × Magnetic Resonance Spectroscopy × Clear all
NCT07415018 2026-04-14

Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease

M.D. Anderson Cancer Center

Phase NA Not yet recruiting
40 enrolled

Meningeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡